OSLO, Norway, Dec. 21, 2023 /PRNewswire/ -- Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, today announces it has renewed its contract with Vitaflo International Limited (Vitaflo International), granting Navamedic the exclusive rights to market and distribute Vitaflo International's medical nutrition products across the Nordic region for an additional five years.

This agreement follows a longstanding partnership between Navamedic and Vitaflo International, dating back to 2005. Vitaflo International's medical nutrition products make up Navamedic's IEM (inborn error of metabolism) products and are part of the Hospital segment.

"We are thrilled to have renewed the contract with Vitaflo International, which underpins the strength of Navamedic's marketing and distribution channels in the Nordics. The medical nutrition product portfolio represents one of Navamedic's key product offerings to our customers in the Nordics, and we look forward to continuing our collaboration and partnership with Vitaflo International," commented Kathrine Gamborg Andreassen, CEO of Navamedic.

For further information, please contact:

Kathrine Gamborg Andreassen, CEO, Navamedic
Mobile: +47 951 78 680
E-mail: kathrine@navamedic.com

Lars Hjarrand, CFO, Navamedic
Mobile: +47 917 62 842
E-mail: lars.hjarrand@navamedic.com

About Navamedic

Navamedic ASA is a full-service provider of high-quality healthcare products to hospitals and pharmacies. Navamedic meets the specific medical needs of patients and consumers by leveraging its highly scalable market access platform, leading category competence and local knowledge. Navamedic is present in all the Nordic countries, the Baltics and Benelux, with sales representation in the UK and Greece. Navamedic is headquartered in Oslo, Norway, and listed on the Oslo Stock Exchange (ticker: NAVA). For more information, please visit Navamedic.com.

View original content:https://www.prnewswire.co.uk/news-releases/navamedic-asa-renewed-contract-signed-with-vitaflo-international-limited-302021149.html

Tags

More Like This

Navamedic ASA: Renewed contract for delivering antibiotics to Norwegian hospitals

Navamedic ASA: Record high quarter with above 50 percent growth

Navamedic Q2 and H1 2024: Stable growth continues and is supported by a new licensing and supply agreement

Navamedic Q4 and full year 2023: A year marked by new records and transformative growth initiatives

Navamedic welcomes new shareholders

Navamedic and Orion Corporation sign non-binding term sheet for Flexilev®in Europe

Navamedic ASA: Amendments to loan agreements with Observe Medical ASA

Navamedic and Orion Corporation sign License & Supply Agreement for Flexilev® in Europe